SCHEMBL21408005

SCHEMBL21408005

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(-c2cc(-c3ccncc3)ccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 1/20 0.46
RECQL P46063 1/20 0.46
PIK3CA P42336 2/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CB P42338 1/20 0.41
MTOR P42345 1/20 0.41
PIK3CG P48736 1/20 0.41
TNKS2 Q9H2K2 1/20 0.39
POLB P06746 1/20 0.38
HSP90AA1 P07900 1/20 0.37
IMPDH2 P12268 1/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21407997 0.92 PIK3CA (0.43) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL29996415 0.90 PDE5A (0.41) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL21421135 0.90 PDE5A (0.41) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL20937193 0.89 ALDH1A1 (0.49) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL29996774 0.88 ALDH1A1 (0.46) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL29996396 0.88 MEN1 (0.34) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL21421139 0.88 MEN1 (0.34) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL20937790 0.88 MAPT (0.45) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL29997134 0.87 ALDH1A1 (0.42) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL31663590 0.86 ALDH1A1 (0.52) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11498914-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-11-15 US disclosed
US-20190300508-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-10-03 US disclosed
US-20190300508-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300508-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 MAPT 112/4885ALDH1A1 242/4885MEN1 3119/4885
US-11498914-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 MAPT 112/4885ALDH1A1 242/4885MEN1 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.